Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Scroll.io | 2024 | Series Unknown | $700K | Victoria |
| ZD Medical | 2024 | Series C | $14.0M | Hangzhou |
| Bioyond Tech | 2024 | Series A | $14.0M | Pudong |
| IntoCare | 2024 | Series D | $10.0M | Suzhou |
| LaNova Medicines | 2024 | Series C | $42.2M | Shanghai |
| Tachem | 2024 | Series B | $9.3M | Zigong |
| Hope Medicine | 2024 | Series B | $18.5M | Nanjing |
| Original Point | 2024 | Series C | $10.7M | Foshan |
| Viewtrix Technology | 2024 | Series Unknown | $2.8M | Shenzhen |
| Mufan Power | 2024 | Series B | $30.2M | Minhang |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | Scroll.io | Series Unknown | $700K | Victoria, Seychelles |
| 127 | ZD Medical | Series C | $14.0M | Hangzhou, China |
| 128 | Bioyond Tech | Series A | $14.0M | Pudong, China |
| 129 | IntoCare | Series D | $10.0M | Suzhou, China |
| 130 | LaNova Medicines | Series C | $42.2M | Shanghai, China |
| 131 | Tachem | Series B | $9.3M | Zigong, China |
| 132 | Hope Medicine | Series B | $18.5M | Nanjing, China |
| 133 | Original Point | Series C | $10.7M | Foshan, China |
| 134 | Viewtrix Technology | Series Unknown | $2.8M | Shenzhen, China |
| 135 | Mufan Power | Series B | $30.2M | Minhang, China |
Scroll.io provides a native zkEVM scaling solution for Ethereum.
ZD Medical is a medical device company that manufactures optical coherence tomography angiography devices.
Bioyond Tech utilizes robotics and artificial intelligence technology to provide modular products and automation solutions.
IntoCare is a high-tech company specializing in surgical products.
LaNova Medicines is a clinical-stage innovative drug research and development company.
Tachem is a research and development manufacturer of protected amino acid series products.
Hope Medicine is a science-driven clinical stage biopharmaceutical company
Original Point focuses on the development of CNC systems with five-axis and multi-axis linkage capabilities.
Viewtrix Technology develops display driver chips and circuit boards, supporting various types of OLED display screens.
Mufan Power provides technical consulting and engineering services for gas turbines, steam turbines and other turbomachinery.
SPEEDIANCE promotes digitization, popularization and platformization of the fitness field, exploring a healthier lifestyle with users.
Pelliot is an outdoor sports brand specializing in innovative design and R&D of outdoor functions.
Guangjing Energy develops perovskite solar cell modules to achieve industrialized mass production and sales.
Chenzhang Bio is a biotechnology developer specializing in stem cell storage and treatment technology.
Dr.Clear Aligner is a provider of orthodontic solutions.
Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.
DST Car is an energy vehicle rental service platform based in Shenzhen.
Novamab focuses on the research and development of new nanobodies.
Alpha Biophama is a clinical stage biopharmaceutical company.
DK Medtech is a leading medical device company specializes in Vascular Interventional products
Horizone Technologies is membrane materials and excellent filtration solutions manufacturer focusing on the R&D and production
Mach Intelligent Driving provides driving solutions with intelligent sensor function modules.
CIX Technology develops high-performance, next-generation intelligent computing solutions.
Jiakekangnuo Bio focuse on technology, promote industrial incubation through strategic investment, and achieves commercialization.
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Qiming Venture Partners has invested in 354 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Qiming Venture Partners's top investment sectors include Health Care, Medical, Biotechnology, Medical Device, Manufacturing. The firm invests across 43 different industry categories.
Among tracked funding rounds, Outpace Bio received $144.0M in a Series B round. Qiming Venture Partners's total known invested capital is $11.0B.
Qiming Venture Partners's average investment size is $54.4M across its portfolio of 354 companies.
Recent Qiming Venture Partners portfolio additions include Scroll.io, ZD Medical, Bioyond Tech, IntoCare, LaNova Medicines. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors